DTI or CLB: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Oil and Gas - Field Services sector might want to consider either Drilling Tools International Corp. (DTI) or Core Laboratories (CLB). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • 14 hours ago

Core Laboratories Q2 Earnings Call Highlights

Core Laboratories NYSE: CLB reported second-quarter 2026 revenue of $124.6 million, up more than 2% from the prior quarter but down 4% from a year earlier, as stronger completion-product sales partly offset disruptions to its service business from conflicts in the Middle East and Russia-Ukraine.

MarketBeat • Jul 31, 2026

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.

Zacks Investment Research • Jul 31, 2026

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.

Zacks Investment Research • Jul 31, 2026

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript

Seeking Alpha • Jul 30, 2026

CORE LAB REPORTS SECOND QUARTER 2026 RESULTS

REVENUE OF $ 124.6 MILLION, UP 2% SEQUENTIALLY AND DOWN 4% YEAR-OVER-YEAR OPERATING INCOME OF $ 9.2 MILLION; EX-ITEMS, $9.4 MILLION, UP 42% SEQUENTIALLY AND DOWN 36% YEAR-OVER-YEAR GAAP EARNINGS PER SHARE OF $0.13; EPS EX-ITEMS OF $0.11, UP 85% SEQUENTIALLY AND DOWN 42% YEAR-OVER-YEAR FREE CASH FLOW OF $ 3.1 MILLION COMPANY REPURCHASED 214,712 SHARES OF COMMON STOCK, FOR $2.7 MILLION AGGREGATE PURCHASE PRICE COMPANY ANNOUNCES Q3 2026 QUARTERLY DIVIDEND HOUSTON, July 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported second quarter 2026 revenue of $124,600,000. Core's operating income was $9,200,000, with earnings per diluted share ("EPS") of $0.13, all in accordance with U.S. generally accepted accounting principles ("GAAP").

PRNewsWire • Jul 29, 2026

Core Laboratories (CLB) Q2 Earnings Surpass Estimates

Core Laboratories (CLB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.19 per share a year ago.

Zacks Investment Research • Jul 30, 2026

What's in Store for Core Laboratories Stock in Q2 Earnings?

CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir description results and higher costs could weigh.

Zacks Investment Research • Jul 23, 2026

Ariel Small/Mid Cap Value Q2 2026 Portfolio Activity

The Ariel Small/Mid Cap Value Composite rose +15.08% gross of fees (+14.95% net of fees) in the quarter, falling short of both the Russell 2500 Value Index's +18.50% return and the +20.26% gain posted by the Russell 2500 Index. Live entertainment, media, and technology company, Sphere Entertainment Co. was the top contributor during the quarter on solid earnings and improving operating fundamentals. Shares of Prestige Consumer Healthcare moved lower following disappointing earnings, driven primarily by ongoing supply constraints in its eye care segment and extended lead times in the Middle East.

Seeking Alpha • Jul 23, 2026

Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jul 22, 2026